DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 47 filers reported holding DEPOMED INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,681,000 | -47.2% | 2,400,000 | -38.0% | 0.06% | -32.6% |
| Q2 2018 | $3,183,000 | +0.6% | 3,871,000 | 0.0% | 0.09% | -14.0% |
| Q1 2018 | $3,165,000 | -2.8% | 3,871,000 | 0.0% | 0.11% | -2.7% |
| Q4 2017 | $3,257,000 | +30.5% | 3,871,000 | +14.8% | 0.11% | +23.6% |
| Q3 2017 | $2,495,000 | -16.0% | 3,371,000 | 0.0% | 0.09% | -19.8% |
| Q2 2017 | $2,969,000 | -6.2% | 3,371,000 | 0.0% | 0.11% | -8.3% |
| Q1 2017 | $3,165,000 | -18.2% | 3,371,000 | 0.0% | 0.12% | -16.6% |
| Q4 2016 | $3,867,000 | -19.8% | 3,371,000 | -0.1% | 0.14% | -15.2% |
| Q3 2016 | $4,820,000 | +16.3% | 3,373,000 | -1.6% | 0.17% | +14.0% |
| Q2 2016 | $4,143,000 | +29.2% | 3,429,000 | 0.0% | 0.15% | +42.9% |
| Q1 2016 | $3,206,000 | -16.7% | 3,429,000 | +1.7% | 0.10% | -16.0% |
| Q4 2015 | $3,847,000 | -19.3% | 3,371,000 | -15.7% | 0.12% | -10.7% |
| Q3 2015 | $4,766,000 | -7.4% | 4,000,000 | 0.0% | 0.14% | +6.9% |
| Q2 2015 | $5,149,000 | – | 4,000,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 5,500,000 | $4,633,000 | 2.75% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 27,019,000 | $22,776,000 | 0.90% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 12,500,000 | $10,563,000 | 0.80% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 51,016,000 | $42,853,000 | 0.76% |
| UBS OCONNOR LLC | 41,000,000 | $34,203,000,000 | 0.61% |
| Man Investments (CH) AG | 600,000 | $508,000 | 0.48% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 20,534,000 | $17,398,000 | 0.33% |
| Senvest Management, LLC | 5,000,000 | $4,228,000 | 0.30% |
| CQS Cayman LP | 4,706,000 | $4,036,000 | 0.26% |
| CSS LLC/IL | 4,436,000 | $3,755,000 | 0.18% |